Introduction:Basic information about CAS 936500-94-6|Elinogrel, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Elinogrel |
|---|
| CAS Number | 936500-94-6 | Molecular Weight | 523.945 |
|---|
| Density | 1.7±0.1 g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C20H15ClFN5O5S2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | 1-(5-chlorothiophen-2-yl)sulfonyl-3-[4-[6-fluoro-7-(methylamino)-2,4-dioxo-1H-quinazolin-3-yl]phenyl]urea |
|---|
| Synonym | More Synonyms |
|---|
Elinogrel BiologicalActivity
| Description | Elinogrel (PRT060128) is a potent, direct acting, competitive, and reversible platelet P2Y12 antagonist (IC50=20 nM). It is orally and intravenously available and has potent antiplatelet effects[1]. |
|---|
| Related Catalog | Research Areas >>Cardiovascular DiseaseSignaling Pathways >>GPCR/G Protein >>P2Y Receptor |
|---|
| Target | IC50: 20 nM (P2Y12)[2] |
|---|
| References | [1]. Angiolillo DJ, et al. Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudyfrom the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circ Cardiovasc Interv. 2012 Jun;5(3):347-56. [2]. Jacobson KA, et al. Pharmacochemistry of the platelet purinergic receptors. Purinergic Signal. 2011 Sep;7(3):305-24. |
|---|
Chemical & Physical Properties
| Density | 1.7±0.1 g/cm3 |
|---|
| Molecular Formula | C20H15ClFN5O5S2 |
|---|
| Molecular Weight | 523.945 |
|---|
| Exact Mass | 523.018738 |
|---|
| PSA | 182.53000 |
|---|
| LogP | 3.02 |
|---|
| Index of Refraction | 1.706 |
|---|
| InChIKey | LGSDFTPAICUONK-UHFFFAOYSA-N |
|---|
| SMILES | CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F |
|---|
Synonyms
| 2-Thiophenesulfonamide, 5-chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]- |
| 5-Chloro-N-({4-[6-fluoro-7-(methylamino)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl]phenyl}carbamoyl)-2-thiophenesulfonamide |
| Elinogrel |
| UNII-915Y8E749J |